11/7 BioPhenoMA raises 190M JPY in Pre-Series A fundraising round

智子川田
Nov 13, 2024
1 min read

Updated: Nov 21, 2024

BioPhenoMA, Inc. (Shinjuku-Ku, Tokyo, Representative Director Daisuke Niwa, CEO Naoto Fujii) raised 190 million JPY from WASEDA University Ventures and JMTC Capital through third party allocation of shares.

【Press Release on PR Times】

https://prtimes.jp/main/html/rd/p/000000009.000132552.html

Recent Posts

See All

2/6 BioPhenoMA launches "TN-cyclon™ ELISA Development Kit"

BioPhenoMA launches the new ultra-sensitive protein detection reagent kit (Product Name: “TN-cyclon™ ELISA Development Kit”) for research...

2/6 Published in The Nikkan Kogyo Shimbun

The Article about our new reagent kit for research was published in The Nikkan Kogyo Shimbun. Read the article (Japanese):...

1/20 Paper published in Journal of Cellular Immunology

Journal of Cellular Immunology Vol. 7 (January issue) published our article “ GRP78: A Multifaceted Role in Cancer Progression and...